Adient (NYSE: ADNT) reported Q3 EPS of $0.32, $0.31 worse than the analyst estimate of $0.63. Revenue for the quarter came in at $3.72 billion versus the consensus estimate of $3.83 billion.

Guidance: FY 2024:

Consolidated Sales: $14.6 billion, versus the consensus of $14.8 billion and prior guidance of $14.8 to $14.9 billion

For earnings history and earnings-related data on Adient (ADNT) click here.